IGC Pharma
29 hedge funds and large institutions have $930K invested in IGC Pharma in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.22% more ownership
Funds ownership: 3.6% → 3.82% (+0.22%)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$54K | |
| 2 | +$16.8K | |
| 3 | +$14K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$11.1K |
| 5 |
Jane Street
New York
|
+$4.08K |
Top Sellers
| 1 | -$40K | |
| 2 | -$5.61K | |
| 3 | -$1.86K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$1.56K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$445 |
